The journey of a healthtech startup with Dr Hemmel
The journey of a healthtech startup with Dr Hemmel
Dr Hemmel Amrania YC21 is the founder of Digistain, a platform cancer diagnostics technology that promises to eliminate the overuse of cytotoxic chemotherapy. He is a world-leading expert in infrared imaging.
He holds the degrees of MSc and PhD in Physics from SupOptique, Paris, and Imperial College London, where his work as a Post Doctorate Researcher in the field of laser-based medical imaging saw him file for 7 patents and receive Imperial College’s Outstanding Research Prize as well as the Royal Society Innovation Award for his contribution to breast cancer imaging. He spearheaded Digistain’s R&D from its beginnings in a physics lab, securing both public and private funding for clinical trials all the way to clinical deployment.
Hemmel’s specialities include quantum detection, microscopic optics, infrared, laser, multispectral, and chemical imaging, on which he is a contributor to the book Vibrational Spectroscopy for Biomedical Applications. His cutting-edge achievements also include two world firsts in the demonstrations of live cell chemical imaging using a benchtop device and intermediate band-gap solid-state solar cells.
Listen here
Subscribe for more
Listen and subscribe to the BioTalent podcast on Apple Podcasts, Spotify or wherever you get your podcasts.
NPS Score
70+ is considered world-class
76
Get in touch
Whether you're hiring or job hunting, we're here to make the process simple. Reach out and let's talk.
All Rights Reserved 2026 BioTalent
